30 Day Trial

ORTHOWORLD » Other Articles of Interest

FDA publishes Summary Information for MONOVISC Injectable Intra-articular Device PMA

Anika Therapeutics received FDA approval to market MONOVISC single-injection treatment for knee osteoarthritis pain, indication for patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e.g., acetominophen). Information now available from FDA includes:

 

Or, access the full summary page from FDA online.

0 COMMENTS

Name
Comment